Sign up Australia
Proactive Investors - Run By Investors For Investors

Holista CollTech cracks formula to produce white bread with low GI level

Holista CollTech cracks formula to produce white bread with low GI level

Australian biotechnology company, Holista Colltech (ASX:HCT) has confirmed that a mix of natural ingredients has been shown to significantly reduce blood sugar levels caused by consuming white bread and other bakery products.

A clinical study on the ingredients was carried out at a leading Australian university in December 2015, with Hollista's proprietary GI Lite formulae and Veripan’s natural sourdough PANATURA® achieved a Glycemic Index (GI) reading of 53, the lowest level ever achieved worldwide in a clean-label white bread.

GI is an indicator of the ability of different types of foods that contain carbohydrate to raise the blood glucose.

A high GI score contain rapidly digested carbohydrates that can trigger a large and rapid rise in the level of blood glucose and potentially the insulin level.

Switzerland-based Veripan AG is Europe's largest independent supplier of specialty bakery ingredients.

The GI formulae, made from extracts of okra (ladies' fingers), dhal (lentils), barley and fenugreek – and Veripan’s natural sourdough PANATURA® provided the breakthrough.

The Australian university research team has been at the forefront of GI research for over a decade, and has determined the GI values of more than 2,500 foods.

Holista and Veripan will jointly distribute the PANATURA® GI which is believed to be the world’s first clean-label low GI White Bread.

Using PANATURA® GI is expected to add a marginal increase to the cost of production and the ingredients will comprise approximately 5-7% of the total flour mix.

The global white bread market is worth an estimated US$170 billion. Rollout will be in Australia first followed by Europe, North America China, India and the rest of Asia.

Overall, the results are highly promising for Hollista given the propensity for white bread consumption in western countries as well as the desire for healthier diets.

 

 

Proactive Investors is a global leader reporting financial news, media, research and hosts events for listed emerging growth companies and investors across four continents.

 

 





Register here to be notified of future HCT Company articles
View full HCT profile View Profile

Holista Colltech Ltd Timeline

Newswire
September 19 2017

Related Articles

man at a micrscope
September 29 2017
The company is a specialist in the storage of stems cells from the umbilical cord, which could provide a potentially life-saving treatment for 82 blood-borne diseases
ventripoint_device.png
June 22 2017
The device can give accurate and rapid volumetric information about all four chambers of the heart
the word antioxidant
August 15 2017
The heparin test is the firm’s lead product; however the company’s OxiChek device for oxidative stress is also gaining traction

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2017

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use